Comments

Relmada Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Relmada Therapeutics (RLMD) operate in?

Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

RLMDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.7002

-0.00600-0.85%

At close: -

$0.7699

0.079.95%

After Hours: Jun 13, 7:10 PM EDT

Relmada Therapeutics (RLMD) Forecast

News Earnings Relmada Therapeutics (RLMD) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Relmada Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RLMD | Benzinga

Explore Relmada Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RLMD.

Open	$0.68
Close	$0.70
Volume / Avg.	200.73K / 1.76M
Day Range	$0.67 - $0.74
52 Wk Range	0.24 - 4.47
Market Cap	$25.55M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	3.47%
Days to Cover	1.04

Recent News

Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Relmada Therapeutics Stock Plummets Losing 80% Value - Here's Why

Relmada Therapeutics reports interim analysis of the Phase 3 Reliance II study for REL-1017 in major depressive disorder, indicating futility in meeting efficacy goals.

Vandana Singh

Nasdaq Surges 150 Points; ISM Services PMI Falls In November

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.68
Close	$0.70
Volume / Avg.	200.73K / 1.76M
Day Range	$0.67 - $0.74
52 Wk Range	0.24 - 4.47
Market Cap	$25.55M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	3.47%
Days to Cover	1.04

About Relmada Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chem...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Relmada Therapeutics (RLMD) stock?

You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.

View our list of the best stock brokerages

Who are Relmada Therapeutics (RLMD) competitors?

Other companies in Relmada Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and SCYNEXIS (NASDAQ:SCYX).

What is the forecast, or price target, for Relmada Therapeutics (RLMD) stock?

Relmada Therapeutics has a consensus price target of $8.83.

What is the current price for Relmada Therapeutics (RLMD)?

The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $0.7699 last updated June 13, 2025 at 7:10 PM EDT.

Does Relmada Therapeutics (RLMD) pay a dividend?

There are no upcoming dividends for Relmada Therapeutics.

When is Relmada Therapeutics (NASDAQ:RLMD) reporting earnings?

Relmada Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is Relmada Therapeutics (RLMD) going to split?

There is no upcoming split for Relmada Therapeutics.

What sector and industry does Relmada Therapeutics (RLMD) operate in?

Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.